Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients

J Am Acad Dermatol. 2021 Dec;85(6):1597-1599. doi: 10.1016/j.jaad.2020.11.055. Epub 2020 Nov 28.

Authors

Nidhi Shah¹, Elizabeth Smith², A Yasmine Kirkorian³

Affiliations

¹ The George Washington University School of Medicine and Health Sciences, Washington, DC.
² The George Washington University, Milken Institute School of Public Health, Washington, DC.
³ The George Washington University School of Medicine and Health Sciences, Washington, DC; Children's National Hospital, Division of Dermatology, Washington, DC. Electronic address: akirkori@childrensnational.org.

PMID: 33259877
DOI: 10.1016/j.jaad.2020.11.055

No abstract available

Publication types

Letter

MeSH terms

Acne Vulgaris / drug therapy*
Child
Dermatologic Agents / adverse effects
Dermatologic Agents / therapeutic use*
Female
Humans
Isotretinoin / adverse effects
Isotretinoin / therapeutic use*
Male
Medication Adherence

Substances

Dermatologic Agents
Isotretinoin